Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
10/04/2026
The shipping index European futures continuous main contract fell by 6% intraday and is now at 1945.10 points.
Latest
3 m ago
The Governor of the Bank of Korea warned that the conflict in the Middle East will worsen inflation.
4 m ago
Hanwang Technology launches a new 7.1-inch e-reader product.
4 m ago
Ali claims HappyHorse: Currently still in internal testing, API will be open soon.
5 m ago
Ceasefire agreement boost Asian stock markets, potentially bringing the best single-week performance since 2022.
5 m ago
According to Mei AI News, Huayuan Securities released a research report on April 10, giving Wumei Biology (603983.SH) a "buy" rating. The main reasons for the rating include: 1) The revenue of eye care and skincare products is growing well; 2) The company's net profit margin has slightly decreased, while the sales expense ratio continues to rise. (Daily Economic News)
See all latest